NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

內視鏡止血設備 (一般外科) :全球市場分析、預測模式 (COVID-19對市場的影響)

Endoscopic Hemostasis Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

出版商 GlobalData 商品編碼 982517
出版日期 內容資訊 英文
訂單完成後即時交付
價格
內視鏡止血設備 (一般外科) :全球市場分析、預測模式 (COVID-19對市場的影響) Endoscopic Hemostasis Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
出版日期: 2020年12月30日內容資訊: 英文
簡介

本報告提供全球內視鏡止血設備市場相關調查,一般外科領域內的定量性的市場趨勢資料,COVID-19對內視鏡止血設備市場的影響的說明,世界、地區、國家等級的市場考察,健康護理系統概要等。

主要的調查內容

  • 現在所販售的內視鏡止血設備及競爭情形發展
    • 主要的產業趨勢的檢討
    • 內視鏡止血設備市場年度總收益:各市場區隔,各市場預測
    • 有關總手術數量,單位,平均銷售價格,及各市場區隔的市場價值的詳細資料
  • 世界,地區,國家等級的市場考察
    • 市場定性的資料,世界、各地區的趨勢,各國市場考察
    • 市場SWOT分析
    • 競爭動態的考察、趨勢
  • 健康護理系統概要
    • 醫療保健制度概要:各國
    • 醫療費償付方針:各國
    • 醫療技術的法規情形:各國

調查對象企業

  • BostonScientific Corp,ConMed Corp,Cook Medical Inc,Diversatek,Inc.,Olympus Corp,US Endoscopy Group,Micro-Tech Endoscopy,Integra LifeSciences Corp,Sklar Surgical Instruments,Merit Medical Systems Inc

調查對象國家

  • 美國,英國,德國,法國,義大利,西班牙,巴西,中國,印度,俄羅斯,日本,澳洲,加拿大,墨西哥,韓國,丹麥,愛爾蘭,荷蘭,紐西蘭,南非,瑞典,瑞士,奧地利,比利時,芬蘭,以色列,挪威,波蘭葡萄牙,台灣,捷克,希臘,匈牙利,土耳其,埃及,沙烏地阿拉伯,阿拉伯聯合大公國,阿根廷,智利

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME717MM

Endoscopic Hemostasis Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within General Surgery therapeutic area.

The model discusses in detail the impact of COVID-19 on Endoscopic Hemostasis Devices market for the year 2020 and beyond. Endoscopic Hemostasis is a technique employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. Since Hemostasis treatment using these devices are performed by means of an endoscope, it is known as Endoscopic Hemostasis.

The indications of Endoscopic Hemostasis technique include various upper and lower gastrointestinal bleeding diseases. Upper GI bleeding mainly includes peptic ulcer bleeding and variceal bleeding while diverticular bleeding and benign anorectal bleeding are the most common etiologies for hospital admissions with lower GI bleeding. Other causes include esophagitis, mallory-weiss syndrome, dieulafoy's lesion, post-polypectomy bleeding, vascular ectasia, radiation proctitis, inflammatory bowel disease and delayed bleeding occurring after endoscopic mucosal resection.

These devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (Hemostatic probes, Hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (Hemostatic spray).

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Endoscopic Hemostasis Devices and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Endoscopic Hemostasis Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Endoscopic Hemostasis Devices market.
  • Competitive dynamics insights and trends provided for Endoscopic Hemostasis Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Boston Scientific Corp, ConMed Corp, Cook Medical Inc, Diversatek, Inc., Olympus Corp, US Endoscopy Group, Micro-Tech Endoscopy, Integra LifeSciences Corp, Sklar Surgical Instruments, Merit Medical Systems Inc

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

  • This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
  • CMO executives who must have deep understanding of the Endoscopic Hemostasis Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Endoscopic Hemostasis Devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Endoscopic Hemostasis Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Endoscopic Hemostasis Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country specific Endoscopic Hemostasis Devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable